title: From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence.
abstract: The implementation of methods of the coronary angioplasty was one of the most important achievement in the field of treatment of coronary artery disease. Abluminal biodegradable polymer stents (BDS) and polymer free stent are the newest and the most promising research concerning coronary stent technology. In this article we discuss the perceived need for BDS-polymer free stents, the current clinical evidence, limits and future perspectives.
authors.affiliation: Interventional Cardio-Angiology Unit, GVM Care and Research, Cotignola, Ravenna, Italy. eliano.navarese@alice.it
authors.forename: E P
authors.initials: EP
authors.lastname: Navarese
authors.forename: F
authors.initials: F
authors.lastname: Castriota
authors.forename: G M
authors.initials: GM
authors.lastname: Sangiorgi
authors.forename: A
authors.initials: A
authors.lastname: Cremonesi
mesh_terms: D020341:Absorbable Implants; D015415:Biomarkers; D001711:Biotransformation; D002986:Clinical Trials as Topic; D023921:Coronary Stenosis / Q000601:surgery; D054855:Drug-Eluting Stents; D005544:Forecasting; D005549:Foreign-Body Reaction / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015337:Multicenter Studies as Topic; D062645:Percutaneous Coronary Intervention / Q000295:instrumentation / Q000379:methods; D011108:Polymers; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D011108:Polymers